immunotherapeutics for cancer and infectious disease

History:

Stressgen Biotechnologies changed their name to Nventa Biopharmaceuticals in 2006.

Spin-offs
Stressgen Bioreagents (2005)

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Southern California North America

Research Focus:
Disease Therapeutics-Research Therapeutics-Development Therapeutics-Clinical early (I, II) Therapeutics:Clinical late (III)

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: